Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Details on Person Kasper, C K

Class:Id	Person:9669987
_displayName	Kasper, C K
_timestamp	2019-12-03 03:53:16
created	[InstanceEdit:9669998] Shamovsky, Veronica, 2019-12-03
firstname	C K
initial	CK
surname	Kasper
(author)	[LiteratureReference:9669991] Hemophilia A due to mutations that create new N-glycosylation sites [LiteratureReference:9670818] Characterization of three abnormal factor IX variants (Bm Lake Elsinore, Long Beach, and Los Angeles) of hemophilia-B. Evidence for defects affecting the latent catalytic site [LiteratureReference:9670825] Replacement of isoleucine-397 by threonine in the clotting proteinase factor IXa (Los Angeles and Long Beach variants) affects macromolecular catalysis but not L-tosylarginine methyl ester hydrolysis. Lack of correlation between the ox brain prothrombin time and the mutation site in the variant proteins [LiteratureReference:9670843] Molecular defect in factor IXBm Lake Elsinore. Substitution of Ala390 by Val in the catalytic domain [LiteratureReference:9671011] Experimental and theoretical evidence supporting the role of Gly363 in blood coagulation factor IXa (Gly193 in chymotrypsin) for proper activation of the proenzyme [LiteratureReference:9673380] Functional consequences of an arginine180 to glutamine mutation in factor IX Hilo
[Change default viewing format]

No pathways have been reviewed or authored by Kasper, C K (9669987)